Response by Jentzer et al to Letters Regarding Article, "Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Mortality in Patients With Cardiogenic Shock"

Circ Heart Fail. 2023 Jul;16(7):e010732. doi: 10.1161/CIRCHEARTFAILURE.123.010732. Epub 2023 Jun 30.

Authors

Jacob C Jentzer¹, P Elliott Miller², Joseph E Tonna^{3

4}

Affiliations

¹ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (J.C.J.).
² Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (P.E.M.).
³ Divisions of Cardiothoracic Surgery (J.E.T.), University of Utah Health and School of Medicine, Salt Lake City.
⁴ Emergency Medicine (J.E.T.), University of Utah Health and School of Medicine, Salt Lake City.

PMID: 37387228
PMCID: PMC10361256
DOI: 10.1161/CIRCHEARTFAILURE.123.010732

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Extracorporeal Membrane Oxygenation* / adverse effects
Heart Failure*
Humans
Hyperoxia* / complications
Oxygenators, Membrane
Retrospective Studies
Shock, Cardiogenic / therapy

Grants and funding